Nova Leap Health Stock Last Dividend Paid
NVLPF Stock | USD 0.20 0.00 0.00% |
Nova Leap Health fundamentals help investors to digest information that contributes to Nova Leap's financial success or failures. It also enables traders to predict the movement of Nova OTC Stock. The fundamental analysis module provides a way to measure Nova Leap's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nova Leap otc stock.
Nova |
Nova Leap Health OTC Stock Last Dividend Paid Analysis
Nova Leap's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
Competition |
Based on the recorded statements, Nova Leap Health has a Last Dividend Paid of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Medical Care Facilities (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Nova Last Dividend Paid Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nova Leap's direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Nova Leap could also be used in its relative valuation, which is a method of valuing Nova Leap by comparing valuation metrics of similar companies.Nova Leap is currently under evaluation in last dividend paid category among its peers.
Nova Fundamentals
Return On Equity | -0.0309 | |||
Return On Asset | -0.0294 | |||
Profit Margin | (0.02) % | |||
Operating Margin | (0.04) % | |||
Current Valuation | 18.18 M | |||
Shares Outstanding | 86.21 M | |||
Shares Owned By Insiders | 36.06 % | |||
Price To Earning | 10.57 X | |||
Price To Book | 1.12 X | |||
Price To Sales | 0.79 X | |||
Revenue | 21.28 M | |||
Gross Profit | 7.21 M | |||
EBITDA | 3.74 M | |||
Net Income | 1.76 M | |||
Cash And Equivalents | 794.12 K | |||
Cash Per Share | 0.01 X | |||
Total Debt | 896.13 K | |||
Debt To Equity | 0.33 % | |||
Current Ratio | 0.87 X | |||
Book Value Per Share | 0.22 X | |||
Cash Flow From Operations | 2.18 M | |||
Beta | 0.66 | |||
Market Capitalization | 16.91 M | |||
Total Asset | 26.77 M | |||
Z Score | 10.8 | |||
Net Asset | 26.77 M |
About Nova Leap Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nova Leap Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nova Leap using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nova Leap Health based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
NVDA | NVIDIA | |
CRESY | Cresud SACIF y | |
GOOG | Alphabet Inc Class C | |
FMC | FMC Corporation | |
XYF | X Financial Class |
Other Information on Investing in Nova OTC Stock
Nova Leap financial ratios help investors to determine whether Nova OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nova with respect to the benefits of owning Nova Leap security.